Ovid Therapeutics DSO Ratio 2011-2026 | OVID

Annual DSO Ratio Ovid Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	4.1	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.1	4.1	4.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	99.7	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	39.1	$ 32.59	-6.89 %	$ 877 M	USA
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.7	3.03 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	198	$ 0.86	-1.42 %	$ 143 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	400	$ 2.8	7.28 %	$ 262 M	Israel
Anika Therapeutics ANIK	76.5	$ 14.88	-0.93 %	$ 213 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Incyte Corporation INCY	66.6	$ 97.16	-0.26 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	20.5	$ 75.56	-0.29 %	$ 12.1 B	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.4	-1.16 %	$ 5.6 M	Israel
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	559	$ 1.61	2.55 %	$ 189 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA